BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17705883)

  • 1. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage.
    Keyrouz SG; Diringer MN
    Crit Care; 2007; 11(4):220. PubMed ID: 17705883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transluminal balloon angioplasty for cerebral vasospasm after spontaneous subarachnoid hemorrhage: A single-center experience.
    Schacht H; Küchler J; Boppel T; Leppert J; Ditz C; Schramm P; Neumann A
    Clin Neurol Neurosurg; 2020 Jan; 188():105590. PubMed ID: 31759310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
    Heffren J; McIntosh AM; Reiter PD
    Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cerebral vasospasm after subarachnoid hemorrhage--a review.
    Wu CT; Wong CS; Yeh CC; Borel CO
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):215-22. PubMed ID: 15679131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebral vasospasm after subarachnoid hemorrhage. Current possibilities of prevention and treatment].
    Stachura K; Danilewicz B
    Przegl Lek; 2002; 59(1):46-8. PubMed ID: 12108047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm].
    Fandino J; Fathi AR; Graupner T; Jacob S; Landolt H
    Neurocirugia (Astur); 2007 Feb; 18(1):16-27. PubMed ID: 17393042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage.
    Ott S; Jedlicka S; Wolf S; Peter M; Pudenz C; Merker P; Schürer L; Lumenta CB
    Biomed Res Int; 2014; 2014():970741. PubMed ID: 24527461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of delayed cerebral ischemia after subarachnoid hemorrhage.
    Koenig MA
    Continuum (Minneap Minn); 2012 Jun; 18(3):579-97. PubMed ID: 22810250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage.
    Daou BJ; Koduri S; Thompson BG; Chaudhary N; Pandey AS
    CNS Neurosci Ther; 2019 Oct; 25(10):1096-1112. PubMed ID: 31583833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk?
    Adami D; Berkefeld J; Platz J; Konczalla J; Pfeilschifter W; Weidauer S; Wagner M
    J Neuroradiol; 2019 Feb; 46(1):15-24. PubMed ID: 29733918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endovascular treatment of cerebral vasospasm due to aneurysmal subarachnoid hemorrhage].
    Alcázar PP; González A; Romance A
    Med Intensiva; 2008 Nov; 32(8):391-7. PubMed ID: 19055932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage.
    Crowley RW; Medel R; Kassell NF; Dumont AS
    Drug Discov Today; 2008 Mar; 13(5-6):254-60. PubMed ID: 18342802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage.
    Kerz T; Boor S; Ulrich A; Beyer C; Hechtner M; Mueller-Forell W
    Br J Neurosurg; 2016 Oct; 30(5):549-53. PubMed ID: 27080311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches to vasospasm in subarachnoid hemorrhage.
    Dorsch NW
    Curr Opin Crit Care; 2002 Apr; 8(2):128-33. PubMed ID: 12386513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on endovascular therapies for cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage.
    Sayama CM; Liu JK; Couldwell WT
    Neurosurg Focus; 2006 Sep; 21(3):E12. PubMed ID: 17029336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of the Management of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
    Li K; Barras CD; Chandra RV; Kok HK; Maingard JT; Carter NS; Russell JH; Lai L; Brooks M; Asadi H
    World Neurosurg; 2019 Jun; 126():513-527. PubMed ID: 30898740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.